ANDA 90665, held by Chartwell Rx. Lidocaine Hydrochloride.
As of Nov 16, 2026, ANDA 90665 (Lidocaine Hydrochloride Preservative Free), held by Chartwell Rx, was first approved by FDA on Sep 27, 2010, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 27, 2010 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Lidocaine Hydrochloride Preservative Free2% ยท injectable;injection | Lidocaine Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters